Zusammenfassung
Dieses Kapitel beschäftigt sich mit der Anwendung von Photochemotherapie und Phototherapie bei Vitiligo. Zunächst wird die Krankheit definiert und werden Differentialdiagnosen und assoziierte Phänomene beschrieben. Allgemeine therapeutische Maßnahmen und Alternativen zu phototherapeutischen Verfahren folgen. Den Hauptteil bildet die Beschreibung der praktischen Durchführung und Wirkung der Bestrahlungsbehandlung mit oder ohne Photosensibilisator sowie von kombinierten Therapieformen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abdel-Fattah A, Aboul-Enein MN, Wassel GM, El-Menshawi BS (1982) An approach to the treatment of vitiligo by khellin. Dermatologica 165: 136–140.
Al’Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ (1994) Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol 131: 160–165.
Alomar A (1992) Some new treatment of vitiligo vulgaris: phototherapy with topical khellin. In: Dermatology: progress and perspectives, 18th World Congress of Dermatology, New York, pp 517–520.
Antoniou C, Katsambas A (1992) Guidelines for the treatment of vitiligo. Drugs 43: 490–498.
Azmi M (1989) Vitiligo repigmentation with Polypodium leucotomos. Int J Dermatol 28: 479.
Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB (1993) An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 170: 149–155.
Bernd A, Ramirez-Bosca A, Huber H et al. (1995) In vitro studies on the immunomodulating effects of Polypodium leucotomos extract on human leukocyte fractions. Arzneim Forsch 45: 901–904.
Bleehen SS (1976) The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies. Br J Dermatol 94 [Suppl 12]: 43–50.
Brown MD, Gupta AK, Ellis CN, Rocher LL, Voorhees JJ (1989) Therapy of dermatologic disease with cyclosporin A. Adv Dermatol 4: 3–27.
Buckley DA, Rogers S (1996) Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol 21: 43–45.
Calanchini-Postizzi E, Frenk E (1987) Long-term actinic damage in sun-exposed vitiligo and normally pigmented skin. Dermatologica 174: 266–271.
Calzavara-Pinton PG, Carlino A, Manfredi E, Semeraro F, Zane C, De Panfilis G (1994) Ocular side effects of PUVA-treated patients refusing eye sun protection. Acta Dermatol Venereol [Suppl 186]: 164–165.
Cormane RH, Siddiqui AH, Westerhof W, Schutgens RB (1985) Phenylalanine and UVA light for the treatment of vitiligo. Arch Derm Res 277: 126–130.
Cox NH, Jones SK, Downey DJ, Tuyp EJ, Jay JL, Moseley H, Mackie RM (1987) Cutaneous and ocular side-effects of oral photochemotherapy: Results of an 8-year follow-up study. Br J Dermatol 116: 145–152.
Cui J, Bystryn JC (1995) Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol 131: 314–318.
Cui J, Arita Y, Bystryn JC (1995) Characterization of vitiligo antigens. Pigment Cell Res 8: 53–59.
Duschet P, Schwarz T, Pusch M, Gschnait F (1989) Marked increase of liver transaminases after khellin and UVA therapy. J Am Acad Dermatol 21: 592–594.
El Mofty AM (1948) A preliminary clinical report on the treatment of leukoderma with Ammi majus Linn. J R Egypt Med Assoc 31: 651–665.
Falabella F (1988) Treatment of localized vitiligo by autologous minigrafting. Arch Dermatol 124: 1649–1655.
Falabella R, Barona M, Escobar C, Borrero I, Arrunategui A (1995) Surgical combination therapy for vitiligo and piebaldism. Derm Surg 21: 852–857.
Frenk E (1986) Behandlung der Vitiligo. Hautarzt 37: 1–5.
Frenk E (1993) Was ist Vitiligo? Akt Dermatol 19: 77–79.
Gokhale BB, Parakh AP (1983) Cyclophosphamide in vitiligo. Ind J Dermatol 28: 7–10.
Gonzalez S, Pathak MA (1996) Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema, and skin photosensitization by Polypodium leucotomos. Photoderm Photoimmunol Photomed 12: 45–56.
Grimes PE, Minus HR, Chakrabarti SG, Enterline J, Halder R, Gough JE, Kenney JA (1982) Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Dermatol 7: 77:-778.
Halder RM, Battle EF, Smith EM (1995) Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol 131: 734–735.
Hann SK, Cho MY, Im S, Park YK (1991) Treatment of vitiligo with oral 5-methoxypsoralen. J Dermatol 18: 324–329.
Harrist TJ, Pathak MA, Mosher DB, Fitzpatrick TB (1984) Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. Natl Cancer Inst Monogr 66:191–196.
Kenney JA (1971) Vitiligo treated by psoralens. A long-term follow-up study of the permanency of repigmentation. Arch Dermatol 103: 475–480.
Khalid M, Mujtaba G, Haroon TS (1995) Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo. Int J Dermatol 34: 203–205.
Koga M (1977) Vitiligo: a new classification and therapy. Br J Dermatol 97: 255–261.
Koster W, Wiskemann A (1990) Phototherapie mit UV-B bei Vitiligo. Zeitschr Hautkrankh 65: 1022–1024.
Kuiters GR, Hup JM, Siddiqui AH, Cormane RH (1986) Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA. J Trop Med Hyg 89: 149–155.
Le Poole IC, Das PK, van den Wijngaard RM, Bos JD, Westerhof W (1993 a) Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2: 145–153.
Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK (1993b) Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 100: 816–822.
Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK (1996) Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148: 1219–1228.
Lerner AB, Halaban R, Klaus SN, Moellmann GE (1987) Transplantation of human melanocytes. J Invest Dermatol 89: 219–224.
Miescher G (1930) Das Problem des Lichtschutzes und der Lichtgewöhnung. Strahlentherapie 35: 403.
Miyares-Cao (1986) Melagenina: ein kubanisches Produkt. Ein neues und wirksames Medikament zur Behandlung der Vitiligo (spanisch). Reihe Nationaler Berichte. Republic of Cuba, Habana, p 18.
Morliere P, Honigsmann H, Averbeck D et al. (1988) Phototherapeutic, photobiologic, and photosensitizing properties of khellin. J Invest Dermatol 90: 720–724.
Mosher DB, Parrish JA, Fitzpatrick TB (1977) Monobenzylether of hydroquinone: a retrospective study of 18 vitiligo patients and a review of the literature. Br J Dermatol 97: 669–679.
Naughton GK, Reggiardo D, Bystryn JC (1986) Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 15: 978–981.
Nordlund JJ, Halder R (1990) Melagenina. An analysis of published and other available data. Dermatologica 181: 1–4.
Nordlund JJ, Ortonne JP (1992) Vitiligo and depigmentation. Curr Probl Dermatol 21: 3–29.
Orecchia G, Perfetti L (1992) Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 184:120–123.
Ortel B (1993) Die Photochemotherapie der Vitiligo - PUVA und KUVA. Akt Dermatol 19: 90–94.
Ortel B, Tanew A, Honigsmann H (1986) Vitiligo treatment. Curr Probl Dermatol 15: 265–271.
Ortel B, Tanew A, Honigsmann H (1988) Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 18: 693–701.
Ortonne JP, Mosher DB, Fitzpatrick TB (1983) Vitiligo and other hypomelanoses of the skin. Plenum, New York.
Pasricha JS, Khaitan BK (1993) Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol 32: 753–757.
Pasricha JS, Khera V (1994) Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease. Int J Dermatol 33: 584–587.
Pathak MA, Fitzpatrick TB (1992) The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol B - Biol 14: 3–22.
Pathak MA, Mosher DB, Fitzpatrick TB, Parrish JA (1980) Relative effectiveness of three psoralens & sunlight in repigmentation of 365 Vitiligo patients. J Invest Dermatol 74: 252.
Ronnerfalt L, Lydahl E, Wennersten G, Jahnberg P, Thyresson-Hok M (1982) Ophthalmological study of patients undergoing long-term PUVA therapy. Acta Derm Venereol 62: 501–505.
Rosenbach T, Wellenreuther U, Nürnberger F, Czarnetzki BM (1993) Behandlung der Vitiligo mit Phenylalanine und UV-A. Hautarzt 44: 208–209.
Schallreuter KU (1992) Klinik und Pathogenese der Vitiligo. In: Macher E, Kolde G, Broecker EB (eds) Jahrbuch der Dermatologie 1991/92. Biermann.
Schallreuter KU, Lemke R, Brandt O et al. (1994a) Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 188: 269–275.
Schallreuter KU, Wood JM, Pittelkow MR et al. (1994b) Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263: 1444–1446.
Schallreuter KU, Wood JM, Lemke KR, Levenig C (1995) Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 190: 223–229.
Schulpis CH, Antoniou C, Michas T, Strarigos J (1989) Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediat Dermatol 6: 332–335.
Sehgal VN (1971) Oral trimethylpsoralen in vitiligo in children: a preliminary report. Br J Dermatol 85: 454–456.
SiddiquiAH, Stolk LM, Bhaggoe R, Hu R, Schütgens RB, Westerhof W (1994) L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 188: 215–218.
Skouge J, Morison WL (1995) Vitiligo treatment with a combination of PUVA therapy and epidermal autografts. Arch Dermatol 131: 1257–1258.
Stern RS, Laird N (1994) The carcinogenic risk of treatments for severe psoriasis. Cancer 73: 2759–2764.
Studniberg HM, Weller P (1993) PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol 29: 1013–1022.
Suite M, Quamina DB (1991) Treatment of vitiligo with topical melagenine - a human placental extract. J Am Acad Dermatol 24: 1018–1019.
Szekeres E, Morvay M (1985) Repigmentation of vitiligo macules treated topically with Efudix cream. Dermatologica 171: 55–59.
Tham SN, Gange RW, Parrish JA (1987) Ultraviolet-B treatment of psoriasis in patients with concomitant vitiligo. Arch Dermatol 123: 26–27.
Thiele B, Steigleder GK (1987) Repigmentierungsbehandlung der Vitiligo mit L-Phenylalanine und UVA-Bestrahlung. Zeitschr Hautkrankh 62: 519–523.
Tsuji T, Hamada T (1983) Topically administered fluorouracil in vitiligo. Arch Dermatol 119: 722–727.
Westerhof W (1993) Differentialdiagnose bei Vitiligo - ein Bildbericht. Akt Dermatol 19: 80–86.
Wildfang IL, Jacobsen FK, Thestrup-Pedersen K (1992) PUVA treatment of vitiligo: a retrospective study of 59 patients. Acta Dermatol Venereol 72: 305–306.
Yagi S, Hanawa S, Morishima T (1983) Morbus Bowen und bowenoide Läsion in Vitiligohaut während prolongierter Phototherapie (japanisch). Nippon Hifuka Gakkai Zasshi - Japan J Dermatol 93: 741–745.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ortel, B., Gonzalez, S. (1997). Photo- und Photochemotherapie der Vitiligo. In: Krutmann, J., Hönigsmann, H. (eds) Handbuch der dermatologischen Phototherapie und Photodiagnostik. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60425-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-60425-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64401-6
Online ISBN: 978-3-642-60425-6
eBook Packages: Springer Book Archive